Filter
2012
Filtered Results: 2012
Text search:
appendix
Featured
Recommendations
164
New Publications
542
Language
Document type
No document type
1301
Studies & Reports
329
Guidelines
195
Manuals
104
Strategic & Response Plan
35
Training Material
27
Fact sheets
12
Resource Platforms
3
Situation Updates
2
Brochures
1
App
1
Infographics
1
Online Courses
1
Countries / Regions
India
97
Kenya
83
Global
79
South Africa
56
Sierra Leone
53
Nigeria
53
Zambia
49
Ghana
46
Malawi
44
Tanzania
44
Liberia
44
Rwanda
39
Uganda
34
Ethiopia
32
Nepal
31
Bangladesh
29
Namibia
27
Myanmar / Burma
24
Philippines
21
Senegal
17
Zimbabwe
16
Guinea
15
Lesotho
14
Africa
14
Western and Central Europe
14
Syria
13
USA
11
Haiti
11
Congo, Democratic Republic of
11
Cambodia
10
Latin America and the Carribbean
10
West and Central Africa
10
Botswana
10
Cameroon
9
Germany
9
Pakistan
9
Mozambique
8
East and Southern Africa
8
Indonesia
8
South–East Asia Region
7
Eswatini/ Swaziland
7
Burkina Faso
6
Asia
6
China
5
Afghanistan
5
Middle East and North Africa
5
Russia
5
Central African Republic
5
Ukraine
4
Jordan
4
United Kingdom
4
Brazil
4
Sudan
4
Turkey
3
Benin
3
Chile
3
Peru
3
North America
3
Lebanon
3
Papua New Guinea
3
South Sudan
3
Ecuador
3
North Macedonia
2
Colombia
2
Thailand
2
Kazakhstan
2
Canada
2
Kyrgyzstan
2
Armenia
2
Southern Africa
2
Sri Lanka
2
Egypt
2
Yemen
2
Honduras
2
Mali
2
Iraq
2
Madagascar
2
Tajikistan
1
Australia
1
Albania
1
Fiji
1
Singapore
1
Burundi
1
Qatar
1
Dominican Republic
1
Venezuela
1
Ireland
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Gabon
1
Turkmenistan
1
Portugal
1
Spain
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Vietnam
1
Moldova
1
Georgia
1
Bhutan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
814
Clinical Guidelines
149
Capacity Building
107
Women & Child Health
106
Key Resources
96
Public Health
89
Pharmacy & Technologies
18
Toolboxes
Mental Health
185
HIV
97
COVID-19
96
Disability
77
Planetary Health
72
TB
69
Caregiver
62
AMR
61
Ebola
59
Pharmacy
44
NCDs
43
Rapid Response
42
Health Financing Toolbox
31
Conflict
31
Refugee
27
Natural Hazards
26
NTDs
24
Global Health Education
24
Specific Hazards
22
Social Ethics
12
Cholera
11
Zika
6
Polio
4
We combine data on Chinese development projects with data from Demographic and Health Surveys to study the impact of Chinese aid on household welfare in sub-Saharan Africa. We use a novel methodology to test the effect of Chinese aid on three important development outcomes: education, health, and nu...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
To support the achievement of health equity in the Region, the regional inter-agency movement Every Woman Every Child Latin America and the Caribbean (EWEC-LAC) advocates for and supports the use of equity and evidence-based policies, strategies and interventions to accelerate equitable progress in ...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
Little is known about the patterns of development assistance (DA) for each component of reproductive, maternal, newborn, child and adolescent health (RMNCAH) in conflict-affected countries nor about the DA allocation in relation to the burden of disease
Donor financing to low- and middle-income countries for reproductive, maternal, newborn, and child health increased substantially from 2008 to 2013. However, increased spending by donors might not improve outcomes, if funds are delivered in ways that undermine countries’ public financial managemen...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The World Heart Federation (WHF) has been advocating globally for stronger
legislation and policy regarding cardiovascular disease (CVD) for many years. Now, as focus shifts from global to national progress, we call on members and colleagues to advocate for greater action on CVD in your local setti...
This report shows that increased domestic revenues can and will cover only part of the necessary SDG budget spending of the LIDCs. Achieving the SDGs in the LIDCs will also require increases of both Official Development Assistance (ODA) and Private Development Assistance (PDA) to reach aggregate lev...
Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spe...
Global progress against cardiovascular disease (CVD) is flatlining.
Though rates of CVD deaths globally have fallen in the last three
decades, this trend has begun to stall and, without concerted
efforts, is at risk of reversing.
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient and sustained response to the epidemic has emerged as one of t...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—differ among...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
